Overlapping area represents amount of risk that can be diversified away by holding Biovail Corp. Common Stoc and Delcath Systems Inc. in the same portfolio (assuming nothing else is changed)
Valeant Pharmaceuticals International, Inc. raised bidding price from $6.50 to $7.50 per share in cash relevant to its earlier proposed price for the acquisition of ISTA Pharmaceuticals.
By Delcath Systems, Inc. NEW YORK, Feb. 9, 2012 -- /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) announced today that Graham G. Miao, Executive Vice President and Chief Financial Officer, will present at the 14th Annual BIO CEO & Investor ...
Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the first patients in Europe have been treated with the Delcath Hepatic CHEMOSAT? Delivery System at the European Institute of Oncology (Instituto Europeo di Oncologia - IEO), a premier cancer ...
By Delcath Systems, Inc. NEW YORK, Feb. 2, 2012 -- /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the first patients in Europe have been treated with the Delcath Hepatic CHEMOSAT? Delivery System at the European Institute of ...
Below are the top 10 best-rated Medical Equipment stocks, based on the percentage of positive ratings by brokerage analysts. One Chinese company (KH) is on the list.
2012-01-30
Company News for January 03, 2012
2012-01-03
Updating Transaction...
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
Filter Tops
Biovail Corp. Common Stoc and 
Delcath Systems Inc.
Delcath Systems Inc.
1.60% 
